Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.
about
Rhizoma Coptidis: A Potential Cardiovascular Protective AgentFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVNon-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis.Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity.Relation of Ectopic Fat with Atherosclerotic Cardiovascular Disease Risk Score in South Asians Living in the United States (from the Mediators of Atherosclerosis in South Asians Living in America [MASALA] Study).Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study.Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients.Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance?Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosisUltrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome
P2860
Q28067054-BC08CA80-8D72-43AF-861E-771BCF895239Q28079826-7CFF8789-1B91-4D56-B238-B2F9A81D9D49Q35841934-8AAC8558-3A9E-431B-BCE1-DC1BAD4F219CQ36953626-448BA2DF-EDFE-4719-B9CF-29538FD4169BQ38711424-73DF3998-7271-4868-B7BA-7316187E1332Q38854485-445F7CF2-C693-4B47-A3DD-0B14DCF8014EQ39181533-FC7B061D-6911-491D-A1CE-DFC67CD5EDE1Q46030615-AD6BC4DF-8693-4F25-A37B-B803F871C3DDQ47429375-FE6154D2-70E8-41D4-B04B-027F5C5355C5Q51313441-48704331-A5C3-40E0-B72B-B76820CA834FQ52359166-149B8C59-0920-4BC5-A5F1-FF44DA12AC27Q54760091-DDE8A57A-2B33-4EC4-80AD-37BF56D97CC5Q58588579-73903888-5911-41CF-A6D9-FE73B53D4BCFQ58711515-C30EF2D5-A96F-4059-8BDA-72785A848FB7
P2860
Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fatty liver predicts the risk ...... population-based cohort study.
@en
Fatty liver predicts the risk ...... population-based cohort study.
@nl
type
label
Fatty liver predicts the risk ...... population-based cohort study.
@en
Fatty liver predicts the risk ...... population-based cohort study.
@nl
prefLabel
Fatty liver predicts the risk ...... population-based cohort study.
@en
Fatty liver predicts the risk ...... population-based cohort study.
@nl
P2093
P2860
P1433
P1476
Fatty liver predicts the risk ...... population-based cohort study.
@en
P2093
Merja Santaniemi
Olavi Ukkola
Pauliina Pisto
Risto Bloigu
Y Antero Kesäniemi
P2860
P304
P356
10.1136/BMJOPEN-2014-004973
P577
2014-03-20T00:00:00Z